Robert F. Kennedy Jr.'s recent actions as head of the Department of Health and Human Services have drawn criticism for delaying key vaccine meetings and initiatives at a time when the U.S. faces serious public health challenges. This includes canceling meetings by the CDC and FDA about flu vaccines and reevaluation of a significant contract with Moderna for mRNA bird flu vaccines. Experts warn that these delays could have detrimental effects on public health and vaccination efforts, particularly during severe flu seasons and outbreaks.
On February 20, the Centers for Disease Control confirmed the postponement of a scheduled March 13 meeting of the Advisory Committee on Immunization Practices (ACIP), an expert panel that develops national vaccine recommendations.
These recent actions by Kennedy's Department of Health and Human Services have raised concerns among public health experts about the delay and re-evaluation of critical vaccine initiatives.
Collection
[
|
...
]